Cetera Investment Advisers
FOLD

Cetera Investment Advisers’s Amicus Therapeutics FOLD Stock Holding History

Cetera Investment Advisers’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,046
Closed -$186K – 4865
2025
Q4 		$186K Sell
13,046
-732
-5% -$7.19K ﹤0.01% 4255
2025
Q3 		$109K Sell
13,778
-46
-0.3% -$327 ﹤0.01% 4309
2025
Q2 		$79.2K Buy
+13,824
New +$89.2K ﹤0.01% 3918
2025
Q1 		– Sell
-11,966
Closed -$113K – 4014
2024
Q4 		$113K Buy
+11,966
New +$124K ﹤0.01% 3557

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Cetera Investment Advisers's FOLD Position: Q1 2026 in Review

Cetera Investment Advisers sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 13,046 shares — an estimated $186K sold.

Cetera Investment Advisers first reported a position in FOLD in Q4 2024 and held it in 4 quarters. The position peaked at $186K in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Cetera Investment Advisers reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Cetera Investment Advisers sold 13,046 Amicus Therapeutics shares in Q1 2026, an estimated $186K.
  • Cetera Investment Advisers first reported a position in Amicus Therapeutics in Q4 2024 and held it in 4 quarters.
  • Cetera Investment Advisers's Amicus Therapeutics position peaked at $186K in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.